Insider Transactions in Q1 2023 at Tg Therapeutics, Inc. (TGTX)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Mar 12 2023	Michael S Weiss CEO	BUY Grant, award, or other acquisition	Direct	985,000 +7.6%	-
Mar 12 2023	Sean A Power CFO	BUY Grant, award, or other acquisition	Direct	85,000 +10.45%	-
Jan 06 2023	Yann Echelard Director	BUY Open market or private purchase	Direct	9,000 +4.27%	$90,000 $10.64 P/Share
Jan 04 2023	Laurence N Charney Director	SELL Open market or private sale	Direct	30,000 -11.33%	$330,000 $11.1 P/Share

Receive a notification when an Institution or Guru buys or sells TGTX shares.

Notify only if

Value

Any

Get notified when an Tg Therapeutics, Inc. insider buys or sells TGTX shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

Receive news related to TG THERAPEUTICS, INC.